Mesh term Alemtuzumab
Browse to parent terms:Antibodies, Monoclonal, Humanized
Description
An anti-CD52 ANTIGEN monoclonal antibody used for the treatment of certain types of CD52-positive lymphomas (e.g., CHRONIC LYMPHOCYTIC LEUKEMIA; CUTANEOUS T-CELL LYMPHOMA; and T-CELL LYMPHOMA). Its mode of actions include ANTIBODY-DEPENDENT CELL CYTOTOXICITY.Search for this term in our Faculty Database
View this term at the NCBI website
